Mechanisms of atrial-selective block of Na+ channels by ranolazine: I. Experimental analysis of the use-dependent block

被引:49
作者
Zygmunt, Andrew C. [1 ]
Nesterenko, Vladislav V. [1 ]
Rajamani, Sridharan [2 ]
Hu, Dan [1 ]
Barajas-Martinez, Hector [1 ]
Belardinelli, Luiz [2 ]
Antzelevitch, Charles [1 ]
机构
[1] Masonic Med Res Lab, Utica, NY 13501 USA
[2] Gilead Sci Inc, Palo Alto, CA USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2011年 / 301卷 / 04期
关键词
ion channels; pharmacology; arrhythmia; antiarrhythmic drugs; CARDIAC SODIUM-CHANNELS; ANTIANGINAL AGENT; LIDOCAINE; REPOLARIZATION; FLECAINIDE;
D O I
10.1152/ajpheart.00242.2011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Zygmunt AC, Nesterenko VV, Rajamani S, Hu D, Barajas-Martinez H, Belardinelli L, Antzelevitch C. Mechanisms of atrial-selective block of Na+ channels by ranolazine: I. Experimental analysis of the use-dependent block. Am J Physiol Heart Circ Physiol 301: H1606-H1614, 2011. First published August 5, 2011; doi:10.1152/ajpheart.00242.2011.-Atrial-selective inhibition of cardiac Na+ channel current (I-Na) and I-Na-dependent parameters has been shown to contribute to the safe and effective management of atrial fibrillation. The present study examined the basis for the atrial-selective actions of ranolazine. Whole cell I-Na was recorded at 15 degrees C in canine atrial and ventricular myocytes and in human embryonic kidney (HEK)-293 cells expressing SCN5A. Tonic block was negligible at holding potentials from -140 to -100 mV, suggesting minimal drug interactions with the closed state. Trains of 40 pulses were elicited over a range of holding potentials to determine use-dependent block. Guarded receptor formalism was used to analyze the development of block during pulse trains. Use-dependent block by ranolazine increased at more depolarized holding potentials, consistent with an interaction of the drug with either preopen or inactivated states, but was unaffected by longer pulse durations between 5 and 200 ms, suggesting a weak interaction with the inactivated state. Block was significantly increased at shorter diastolic intervals between 20 and 200 ms. Responses in atrial and ventricular myocytes and in HEK-293 cells displayed a similar pattern. Ranolazine is an open state blocker that unbinds from closed Na+ channels unusually fast but is trapped in the inactivated state. Kinetic rates of ranolazine interactions with different states of atrial and ventricular Na+ channels were similar. Our data suggest that the atrial selectivity of ranolazine is due to a more negative steady-state inactivation curve, less negative resting membrane potential, and shorter diastolic intervals in atrial cells compared with ventricular cells at rapid rates.
引用
收藏
页码:H1606 / H1614
页数:9
相关论文
共 32 条
  • [1] [Anonymous], 1998, Applied Regression Analysis
  • [2] Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties
    Antzelevitch, C
    Belardinelli, L
    Zygmunt, AC
    Burashnikov, A
    Di Diego, JM
    Fish, JM
    Cordeiro, JM
    Thomas, G
    [J]. CIRCULATION, 2004, 110 (08) : 904 - 910
  • [3] Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation
    Antzelevitch, Charles
    Burashnikov, Alexander
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2009, 42 (06) : 543 - 548
  • [4] LIDOCAINE BLOCK OF CARDIAC SODIUM-CHANNELS
    BEAN, BP
    COHEN, CJ
    TSIEN, RW
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 1983, 81 (05) : 613 - 642
  • [5] Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation - Differences in sodium channel inactivation between atria and ventricles and the role of ranolazine
    Burashnikov, Alexander
    Di Diego, Jose M.
    Zygmunt, Andrew C.
    Belardinelli, Luiz
    Antzelevitch, Charles
    [J]. CIRCULATION, 2007, 116 (13) : 1449 - 1457
  • [6] New Pharmacological Strategies for the Treatment of Atrial Fibrillation
    Burashnikov, Alexander
    Antzelevitch, Charles
    [J]. ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2009, 14 (03) : 290 - 300
  • [7] Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation
    Burashnikov, Alexander
    Di Diego, Jose M.
    Sicouri, Serge
    Ferreiro, Marceta
    Carlsson, Leif
    Antzeevitch, Charles
    [J]. HEART RHYTHM, 2008, 5 (12) : 1735 - 1742
  • [8] Antiarrhythmic drugs and cardiac ion channels: mechanisms of action
    Carmeliet, E
    Mubagwa, K
    [J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1998, 70 (01) : 1 - 72
  • [9] Pharmacogenetics and anti-arrhythmic drug therapy: a theoretical investigation
    Clancy, Colleen E.
    Zhu, Zheng I.
    Rudy, Yoram
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (01): : H66 - H75
  • [10] Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action
    Fredj, Sandra
    Sampson, Kevin J.
    Liu, Huajun
    Kass, Robert S.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (01) : 16 - 24